NIH-funded research R01 grant

Understanding how chromosomal instability affects the severity of prostate cancer

Official title: Investigating the impact of chromosomal instability on prostate cancer aggressiveness

Funded at Mayo Clinic Rochester · NIH-10993877 · Data updated 2026-11-12

This study is looking at how certain changes in chromosomes might make prostate cancer more aggressive, and it's for men with prostate cancer who want to learn about new ways to treat their condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startJuly 8, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$485,354
NIH project number1R01CA294563-01
Project IDNIH-10993877 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are men diagnosed with metastatic prostate cancer exhibiting high levels of chromosomal instability.

Less likely to help

Patients with early-stage prostate cancer or those without chromosomal instability may not benefit from this research.

What this research studies

This research investigates the role of chromosomal instability (CIN) in the aggressiveness of prostate cancer, a leading cause of cancer-related deaths in men. By utilizing advanced techniques such as genetic analysis, proteomics, and high-resolution microscopy, the study aims to uncover the molecular mechanisms linking CIN to the survival and adaptation of prostate cancer cells. The researchers will focus on the role of MASTL kinase in regulating processes that may contribute to cancer progression and immune response. Patients may benefit from insights that could lead to new therapeutic strategies targeting aggressive prostate cancer.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options for patients with aggressive prostate cancer.

How similar studies have gone: Previous research has shown that targeting chromosomal instability in cancer can lead to significant advancements in treatment, suggesting potential success for this approach.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Rodriguez-Bravo, Veronica — Mayo Clinic Rochester
  • Study coordinator: Rodriguez-Bravo, Veronica

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.